SCHEMBL99738

SCHEMBL99738

O=C(O)CCCC(=O)c1ccc(-c2ccccc2)c([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
LMNA P02545 2/20 0.44
FFAR1 O14842 1/20 0.44
CYP1A2 P05177 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HIF1A Q16665 1/20 0.44
FBP1 P09467 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98419 0.92 CYP1A2 (0.54) ALDH1A1TDP1LMNAFFAR1CYP1A2
SCHEMBL11541099 0.82 MAPT (0.53) ALDH1A1TDP1LMNARAB9ASMN1; SMN2
SCHEMBL99918 0.80 CASP6 (0.64) ALDH1A1TDP1LMNAMAPTCASP6
SCHEMBL9412619 0.80 VCAM1 (0.60) ALDH1A1LMNASMN1; SMN2MAPTHPGD
SCHEMBL99169 0.80 CASP6 (0.44) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL28126129 0.80 LMNA (0.63) ALDH1A1TDP1LMNARAB9ASMN1; SMN2
SCHEMBL7108991 0.78 HDAC1 (0.50) TDP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL8441836 0.77 MAPT (0.59) ALDH1A1TDP1SMN1; SMN2MAPTMEN1
SCHEMBL9171787 0.77 ALDH1A1 (0.54) ALDH1A1TDP1LMNARAB9AMAPT
SCHEMBL11696700 0.77 ALDH1A1 (0.54) ALDH1A1TDP1LMNARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9072734-B2 Quaternary ammonium salt compounds TEIJIN PHARMA LIMITED (JP) 2015-07-07 US disclosed
CN-102459231-B Quaternary ammonium salt compound TEIJIN PHARMA LTD 2015-04-22 CN disclosed
CN-102459231-A Quaternary ammonium salt compound TEIJIN PHARMA LTD 2012-05-16 CN disclosed
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP disclosed
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS TEIJIN PHARMA LIMITED (JP) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS ADRB2, AGTR2, ADRB3 ALDH1A1 1896/4885TDP1 4429/4885HDAC3 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.